HomePress-release

Redding, California - October 29, 2024

Human Milk Oligosaccharides (HMOs) Market to Reach $1.71 Billion by 2031

Human Milk Oligosaccharides (HMOs) Market Size, Share, Forecast, & Trends Analysis by Type (2'FL, 3'FL, 3'SL, 6'SL, LNT, LNnT), Concentration (Neutral, Acidic), Application (Infant Formula, Dietary Supplements, Food & Beverages)—Global Forecast to 2031

Meticulous Research^®—a leading global market research company, published a research report titled ‘Human Milk Oligosaccharides (HMOs) Market—Global Opportunity Analysis and Industry Forecast (2024-2031)’. According to this latest publication, the human milk oligosaccharides (HMOs) market is expected to reach $1.71 billion by 2031, at a CAGR of 21.2% from 2024 to 2031.

The human milk oligosaccharides (HMOs) market is experiencing growth driven by increasing demand for infant nutrition, a surge in dietary supplement consumption, growing awareness of the benefits of HMOs, and enhanced product innovation by various manufacturers. However, the high cost of HMOs and the availability of alternative oligosaccharides in the market may hinder this growth.

Moreover, ongoing technological advancements and government approvals for the use of HMOs in human consumption present significant opportunities for market participants. However, the market also encounters considerable challenges, including complex production processes and stringent regulatory requirements. Conversely, the growing trend toward clean-label products is becoming increasingly prominent within the human milk oligosaccharides (HMOs) market.

Key Players:

The human milk oligosaccharides (HMOs) market is characterized by a moderately competitive scenario due to the presence of many large- and small-sized global, regional, and local players. The key players operating in the human milk oligosaccharides (HMOs) market are Chr. Hansen A/S (A part of Novonesis) (Denmark), DSM-Firmenich AG (Switzerland), Kyowa Hakko Europe GmbH (Germany), Royal FrieslandCampina N.V. (Netherlands), ZuChem Inc. (U.S.), ELICITYL S.A. (France), Dextra Laboratories Limited (U.K.), Glycosyn LLC (U.S.), Nestle Health Science (U.S.), Biosynth Ltd (U.K.), Inbiose NV (Belgium), BASF SE (Germany), and Abbott Laboratories (U.S.), among others.

The human milk oligosaccharides (HMOs) market is segmented based on type, concentration, and application. The report also evaluates industry competitors and analyzes the human milk oligosaccharides (HMOs) market at the regional and country levels.

By type, the 2’FL segment is expected to account for the largest share of the human milk oligosaccharides market in 2024. This segment’s substantial market share can be attributed to its robust product availability since its approval in 2016, the increasing preference for HMOs driven by their extensive health benefits and diverse applications, the heightened demand for HMO-enriched infant formulas, and the rising integration of 2'FL into these infant formula products.

By concentration, the neutral segment is expected to account for the largest share of the human milk oligosaccharides (HMOs) market in 2024. This segment's large market share is attributed to the high utilization of neutral HMOs, including 2’FL, and the high approval of neutral products in various countries for incorporation in infant formulas. Also, neutral HMOs have prebiotic effects that enhance gut health and support the immune system in infants.

By application, the infant formula segment is expected to account for the largest share of the human milk oligosaccharides market in 2024. The large market share of this segment is attributed to the rising demand for working professional women for their newborn babies, the growing incorporation of HMOs by various infant nutrition manufacturers, and the launching of various innovative products. Moreover, increasing awareness regarding the use of HMOs for infant nutrition, including defending infants from infections, enhancing their memory, promoting prebiotic effects, supporting brain development, and maintaining gut health, further supports the growth of the market.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa).

By geography, North America is expected to account for the largest share of the human milk oligosaccharides market in 2024, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa. The significant share of this regional market can be attributed to several key factors, including heightened awareness of the nutritional benefits of HMOs, increasing consumer demand for HMO-based products, a rising trend toward personalized nutrition with an emphasis on gut health, advancements in technology within the region, and strong governmental support for regulatory frameworks and policies.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6065

Key Questions Answered in the Report-

What is the value of revenue generated by the sale of human milk oligosaccharides (HMOs)?
At what rate is the global demand for human milk oligosaccharides (HMOs) projected to grow for the next five to seven years?
What is the historical market size and growth rate for the human milk oligosaccharides (HMOs) market?
What are the major factors impacting the growth of this market at global and regional levels?
What are the major opportunities for existing players and new entrants in the market?
Which type, concentration, and application segments create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the human milk oligosaccharides (HMOs) market?
Who are the major players in the human milk oligosaccharides (HMOs) market? What are their specific product offerings in this market?
What recent developments have taken place in the human milk oligosaccharides (HMOs) market? What impact have these strategic developments created on the market?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & Wastewater Technologies

Miscellaneous / Others

Redding, California - October 29, 2024

Human Milk Oligosaccharides (HMOs) Market to Reach $1.71 Billion by 2031

Human Milk Oligosaccharides (HMOs) Market Size, Share, Forecast, & Trends Analysis by Type (2'FL, 3'FL, 3'SL, 6'SL, LNT, LNnT), Concentration (Neutral, Acidic), Application (Infant Formula, Dietary Supplements, Food & Beverages)—Global Forecast to 2031

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies